Zacks: Analysts Anticipate ContraFect Corporation (CFRX) to Post -$0.16 Earnings Per Share

Brokerages predict that ContraFect Corporation (NASDAQ:CFRX) will post earnings per share (EPS) of ($0.16) for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for ContraFect Corporation’s earnings. The lowest EPS estimate is ($0.17) and the highest is ($0.15). ContraFect Corporation reported earnings per share of ($0.35) during the same quarter last year, which would suggest a positive year over year growth rate of 54.3%. The company is expected to report its next quarterly earnings report on Tuesday, August 8th.

According to Zacks, analysts expect that ContraFect Corporation will report full-year earnings of ($0.70) per share for the current financial year, with EPS estimates ranging from ($0.75) to ($0.66). For the next year, analysts anticipate that the firm will report earnings of ($0.76) per share, with EPS estimates ranging from ($0.87) to ($0.63). Zacks’ earnings per share calculations are an average based on a survey of sell-side research analysts that that provide coverage for ContraFect Corporation.

ContraFect Corporation (NASDAQ:CFRX) last issued its quarterly earnings results on Monday, May 8th. The biotechnology company reported ($0.15) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.17) by $0.02.

Separately, Maxim Group reaffirmed a “hold” rating on shares of ContraFect Corporation in a research report on Wednesday, March 15th.

A hedge fund recently bought a new stake in ContraFect Corporation stock. Westfield Capital Management Co. LP purchased a new position in shares of ContraFect Corporation (NASDAQ:CFRX) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 149,600 shares of the biotechnology company’s stock, valued at approximately $269,000. Westfield Capital Management Co. LP owned about 0.36% of ContraFect Corporation as of its most recent SEC filing. Hedge funds and other institutional investors own 44.64% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Zacks: Analysts Anticipate ContraFect Corporation (CFRX) to Post -$0.16 Earnings Per Share” was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece on another site, it was illegally copied and republished in violation of United States and international copyright & trademark law. The correct version of this piece can be viewed at

Get a free copy of the Zacks research report on ContraFect Corporation (CFRX)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for ContraFect Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraFect Corporation and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply